Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response
Translational Research · 2025
DOI: 10.1016/j.trsl.2025.05.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Research, 2025. Verfasst von Hua Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Depa…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Epigenesis, Genetic, Endogenous Retroviruses, Colorectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan University, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Colorectal cancer (CRC) is one of the most common cancers worldwide. Although immune checkpoint blockade (ICB) has transformed CRC treatment, the low response rate and immune resistance remain significant challenges. In recent years, epigenetic therapies have been shown to induce viral mimicry response to overcome immune resistance and increase the effectiveness of ICB. However, as an epigenetic modifier, the intrinsic function of PRMT5 in controlling innate immune signaling, viral mimicry, and the tumor microenvironment in CRC remains to be elucidated. Here, we report that PRMT5 inhibition attenuates CRC growth and epigenetically targeting PRMT5 remolds the tumor immune microenvironment, thereby enhancing the therapeutic efficacy of ICB. Mechanistically, PRMT5 knockdown increases endogenous retroviruses (ERVs) expression and dsRNA formation and causes DNA repair incompetence and genomic instability. These changes, combined with the elevated expression of RIG-I/MDA5/STING, trigger innate immune activation and viral mimicry response, thereby facilitating immune cell infiltration and enhancing ICB effectiveness. Furthermore, PRMT5 knockdown reduces H3R2me2s and H3R8me2s levels, and epigenetically promotes innate immune responses. Our study reveals the tumor intrinsic role of PRMT5 in controlling ERVs and innate sensors expression, providing perspectives for the epigenetically targeting of PRMT5 to induce viral mimicry response and enhance antitumor immunity in CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China; Department of Pathology, General Hospital of Western Theater Command, Chen…
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, 610041, China; Sichuan Clinical Research Center for Laboratory Medicine, Chengdu, 610041,…
- Department of Pathology, General Hospital of Western Theater Command, Chengdu, 610083, China.
- Department of Pathology, General Hospital of Western Theater Command, Chengdu, 610083, China. Electronic address: 190526057@qq.com.
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address: denghongx@scu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Sichuan University
- Sichuan Province Science and Technology Support Program
- West China Hospital of Sichuan University
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, H., Shi, G., Li, Y., Wang, C., Zhang, Y., Luo, Y., Xu, J., Qiu, Y., Ma, J., Yang, J., Liao, D., Chen, Y., & Deng, H. (2025). Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response. Translational Research. https://doi.org/10.1016/j.trsl.2025.05.007
Vancouver
Zhang H, Shi G, Li Y, Wang C, Zhang Y, Luo Y, et al. Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response. Translational Research. 2025. doi:10.1016/j.trsl.2025.05.007
BibTeX
@article{Zhang2025,
author = {Zhang, Hua and Shi, Gang and Li, Yamei and Wang, Chao and Zhang, Yong and Luo, Yan and Xu, Jia and Qiu, Yusha and Ma, Jinhu and Yang, Jin and Liao, Dandan and Chen, Yihua and Deng, Hongxin},
title = {Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response},
journal = {Translational Research},
year = {2025},
doi = {10.1016/j.trsl.2025.05.007}
}
EUVIMED